抗Human MMP-9抗体(Anti-Human MMP-9 antibody)

掲載日情報:2019/10/21 現在Webページ番号:28655

Human MMP-9に対する抗体(Anti-Human MMP-9 )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-Human MMP-9 MAb (Clone 4H3)
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 33
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
別名:92 kDa gelatinase
クローン:4H3
Genbank No: 4318
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 IHC,IP,Western Blot
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 Myeloid-derived Suppressor Cell Marker
関連記事
Anti-Human MMP-9 MAb (Clone 4H3)
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 1
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
※受注発注品。形状:溶液または凍結乾燥
別名:92 kDa gelatinase
クローン:4H3
Genbank No: 4318
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 IHC,IP,Western Blot
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 使いっきり抗体
Myeloid-derived Suppressor Cell Marker
関連記事

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-Human MMP-9 MAb (Clone 4H3)

文献数: 33

説明文 別名:92 kDa gelatinase
クローン:4H3
Genbank No: 4318
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 IHC,IP,Western Blot
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 Myeloid-derived Suppressor Cell Marker
関連記事

Anti-Human MMP-9 MAb (Clone 4H3)

文献数: 1

説明文 ※受注発注品。形状:溶液または凍結乾燥
別名:92 kDa gelatinase
クローン:4H3
Genbank No: 4318
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 IHC,IP,Western Blot
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 使いっきり抗体
Myeloid-derived Suppressor Cell Marker
関連記事



目次に戻る

Product Details

Species ReactivityHuman
LabelUnconjugated
ImmunogenChinese hamster ovary cell line CHO-derived recombinant human MMP-9
SourceMonoclonal Mouse IgG1 Clone # 4H3
PurificationProtein A or G purified from ascites
SpecificityDetects human MMP-9 in Western blots. In Western blots, reactivity with the pro (92 kDa), active (82 kDa), and C-terminal truncated (65 kDa) forms of recombinant human (rh) MMP-9 is observed. Also in Western blots, 20% cross-reactivity with rhMMP-2, 5% cross‑reactivity with rhMMP-1, and no cross-reactivity with rhMMP-3, -7, -8, -10, -12, or -13 is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Western Blot2 µg/mLSee below
Immunohistochemistry25-100 µg/mLImmersion fixed paraffin-embedded sections of human ovarian and breast cancer tissues
Immunoprecipitation25 µg/mLConditioned cell culture medium spiked with Recombinant Human MMP‑9 (Catalog # 911-MP), see our available Western blot detection antibodies
CyTOF-reportedBrodie, T.M. et al. (2018) Cytometry PartA. 93: 406. Ready to be labeled using establishedconjugation methods. No BSA or other carrier proteins that could interfere withconjugation.


Western Blot
Detection of Human MMP‑9 by Western Blot.
Western blot shows lysates of U937 human histiocytic lymphoma cell line untreated (-) or treated (+) with 5 ng/mL PMA for 24 hours. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human MMP‑9 Monoclonal Antibody (Catalog # MAB911) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF018). A specific band was detected for MMP‑9 at approximately 85 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.


目次に戻る

Related Product & Information

Long NameMatrix Metalloproteinase 9
BackgroundMMP-9
background_contentBackground:
MMP-9
Matrix metalloproteinases are a family of zinc and calcium dependent endopeptidases with the combined ability to degrade all the components of the extracellular matrix. MMP-9 (Gelatinase B) can degrade a broad range of substrates including gelatin, collagen types IV and V, elastin and proteoglycan core protein. It is believed to act synergistically with interstitial collagenase (MMP-1) in the degradation of fibrillar collagens as it degrades their denatured gelatin forms. MMP-9 is produced by keratinocytes, monocytes, macrophages and PMN leukocytes. MMP-9 is present in most cases of inflammatory responses. Structurally, MMP-9 maybe be divided into five distinct domains: a pro-domain which is cleaved upon activation, a gelatin-binding domain consisting of three contiguous fibronectin type II units, a catalytic domain containing the zinc binding site, a proline-rich linker region, and a carboxyl terminal hemopexin-like domain.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. Diverse matrix metalloproteinase functions regulate cancer amoeboid migration.
    Authors: Orgaz J, Pandya P, Dalmeida R, Karagiannis P, Sanchez-Laorden B, Viros A, Albrengues J, Nestle F, Ridley A, Gaggioli C, Marais R, Karagiannis S, Sanz-Moreno V
    Nat Commun, 2014;5(0):4255.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB

  2. High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.
    Authors: Teles RM, Teles RB, Amadeu TP, Moura DF, Mendonca-Lima L, Ferreira H, Santos IM, Nery JA, Sarno EN, Sampaio EP
    Infect. Immun., 2010;78(3):1012-21.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC Frozen

  3. The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy.
    Authors: Li MQ, Hou XF, Shao J, Tang CL, Li DJ
    Biol. Reprod., 2010;82(5):968-79.
    Species: Human
    Sample Type: Whole Cells
    Application: Cell-based ELISA

  4. Matrix metalloproteinase activity in pediatric acute lung injury.
    Authors: Kong MY, Gaggar A, Li Y
    Int J Med Sci, 2009;6(1):9-17.
    Species: Human
    Sample Type: Tissue Secretion
    Application: WB

  5. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
    Authors: Lucio-Eterovic AK, Piao Y, de Groot JF
    Clin. Cancer Res., 2009;15(14):4589-99.
    Species: Human
    Sample Type: Cell Culture Supernates
    Application: WB

  6. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Authors: Madsen EL, Bruun JM, Skogstrand K, Hougaard DM, Christiansen T, Richelsen B
    Metab. Clin. Exp., 2009;58(7):946-53.
    Species: Human
    Sample Type: Serum
    Application: Luminex Assay Development

  7. Expression pattern and circulating levels of endostatin in patients with pancreas cancer.
    Authors: Ohlund D, Ardnor B, Oman M, Naredi P, Sund M
    Int. J. Cancer, 2008;122(12):2805-10.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC Frozen

  8. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
    Authors: Gupta K, Shukla M, Cowland JB, Malemud CJ, Haqqi TM
    Arthritis Rheum., 2007;56(10):3326-35.
    Species: Human
    Sample Type: Synovial Fluid
    Application: IP

  9. IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis.
    Authors: Caruso R, Fina D, Peluso I, Fantini MC, Tosti C, Del Vecchio Blanco G, Paoluzi OA, Caprioli F, Andrei F, Stolfi C, Romano M, Ricci V, MacDonald TT, Pallone F, Monteleone G
    J. Immunol., 2007;178(9):5957-65.
    Species: Human
    Sample Type: Cell Culture Supernates
    Application: WB

  10. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma.
    Authors: Kleinman ME, Greives MR, Churgin SS, Blechman KM, Chang EI, Ceradini DJ, Tepper OM, Gurtner GC
    Arterioscler. Thromb. Vasc. Biol., 2007;27(12):2664-70.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC Paraffin-embedded



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。